Prothena Corporation plc

89 articles with Prothena Corporation plc

• Prothena Corporation plc CEO Diagnosed With Pancreatic Cancer

  12/3/2014

• Prothena Corporation plc Reports Third Quarter 2014 Financial Results And R&D Progress

  11/4/2014

• Prothena Corporation plc Announces Presentation At Federation Of European Physiological Societies 2014 Congress

  8/27/2014

• Prothena Corporation plc Release: Dr. Dale Schenk To Discuss Parkinson's Disease At 2014 Rejuvenation Biotechnology Conference

  8/19/2014

• Prothena Corporation plc Reports Second Quarter 2014 Financial Results And R&D Progress

  8/4/2014

• Prothena Corporation plc Release: Initiation Of Multiple Ascending Dose Phase 1 Study Of PRX002 In Patients With Parkinson's Disease

  8/1/2014

• Prothena Corporation plc Announces Pricing Of Public Offering Of 4,750,000 Ordinary Shares

  6/25/2014

• Prothena Corporation plc Announces Proposed Offering Of Ordinary Shares

  6/24/2014

• Prothena Corporation plc To Present At The Jefferies and Co. 2014 Global Healthcare Conference In New York

  5/28/2014

• Prothena Corporation plc Reports First Quarter 2014 Financial Results And Provides R&D Updates

  5/6/2014

• Prothena Corporation plc To Host Webcast And Conference Call To Discuss Interim Phase 1 Data Of Ongoing NEOD001 Study In Patients With AL Amyloidosis On May 2

  5/2/2014

• Prothena Corporation plc Announces Appointment Of Chief Legal Officer

  5/1/2014

• Prothena Corporation plc's NEOD001 Demonstrates Encouraging Cardiac Biomarker Responses In Ongoing Phase 1 Study In Patients With Immunoglobulin Light Chain (AL) Amyloidosis

  4/23/2014

• Prothena Corporation plc Release: First Human Dosed In Phase 1 Study Of PRX002 For Treatment Of Parkinson's Disease

  4/9/2014

• Prothena Corporation plc Announces Clinical Data To Be Presented At The International Symposium On Amyloidosis

  3/19/2014

• Prothena Corporation plc Reports Fourth Quarter And Full Year 2013 Financial Results And Provides Research And Development Update

  3/7/2014

• Prothena Corporation plc Announces Appointment Of Chief Business Officer

  3/4/2014

• Prothena Corporation plc To Report Fourth Quarter And Full Year 2013 Financial Results And Host Webcast And Conference Call On March 6

  2/19/2014

• Prothena Corporation plc Announces Closing Of Underwritten Public Offering Of Ordinary Shares And Full Exercise Of Underwriters' Option To Purchase Additional Ordinary Shares From Perrigo

  2/4/2014

• Prothena Corporation plc Announces Pricing Of Secondary Offering Of Ordinary Shares By Perrigo Company

  1/29/2014